Simon Lewin Adherence to TB Medication PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238 SIMON LEWIN, London School of Hygiene and Tropical Medicine A new systematic review has shown that we don

Simon Lewin
Adherence to TB Medication
PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238SIMON LEWIN, London School of Hygiene and Tropical MedicineA new systematic review has shown that we don’t understand well enough the reasons for poor adherence to tuberculosis medication.Simon Lewinof the London School of Hygiene and Tropical Medicine calls for a better approach in the area.

Nancy Padian

David Mabey
Where Now for HIV Prevention Trials?
REFERENCE: The Lancet 2007; 370:251-261NANCY PADIAN, University of California, San FranciscoCOMMENT: DAVID MABEY, London School of Hygiene and Tropical MedicineA major study testing a latex diaphragm for HIV prevention found no additional benefit. This adds to a growing number of HIV prevention trials that have failed to find a positive result. So what do we do now?Nancy Padianof the University of California, San Francisco, explains the trial’s results, whileDavid Mabeyof LSHTM suggests the field needs greater funding.
